References
- World Health Organization. Report of the First Meeting of the W.H.O. Alliance for the Global Elimination of Trachoma. Geneva: World Health Organization, 1997.
- Schachter J, et al. Azithromycin in control of trachoma. Lancet. 1999;354:630–635.
- Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: How frequently should we administer mass chemotherapy? Nat Med. 1999;5:572–576.
- Adegbola RA, et al. Effect of azithromycin on pharyngeal microflora. Pediatr Infect Dis 1995;14:335–337.
- Leach AJ, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis. 1997;24:356–362.
- Chern KC, et al. Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. Br J Ophthalmol. 1999;83:1332–1335.
- Taylor A. Mathematics and politics: Strategy, voting, power and proof New York: Springer-Verlag, 1995.
- World Health Organization. Anatomical Therapeutic Chemical Classification Index with Defined Daily Doses. Oslo: WHO Collaborating Centre for Drug Statistics Methodology and the Nordic Council on Medicines, 2000.
- World Health Organization. Guidelines for Anatomical Therapeutic Chemical Classification and Defined Daily Dose Assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methodology and the Nordic Council on Medicines, 2000.
- Osaki Holm S, et al. Azithromycin distribution strategies for trachoma. Bull WHO. 2001;79:194–200.
- Seppala H, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337:441–446.